Burning Rock Reports First Quarter 2023 Financial Results
30 mai 2023 00h53 HE
|
Burning Rock Biotech Limited
GUANGZHOU, China, May 30, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation...
Burning Rock Provides First Quarter 2023 Business Updates and Schedules Earnings Release on May 30, 2023
27 avr. 2023 01h01 HE
|
Burning Rock Biotech Limited
GUANGZHOU, China, April 27, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation...
Burning Rock Publishes 2022 Annual Report on Form 20-F
20 avr. 2023 22h43 HE
|
Burning Rock Biotech Limited
GUANGZHOU, China, April 20, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation...
Burning Rock Reports Fourth Quarter and Full Year 2022 Financial Results
28 mars 2023 02h08 HE
|
Burning Rock Biotech Limited
GUANGZHOU, China, March 28, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation...
Burning Rock Schedules Fourth Quarter and Full Year 2022 Earnings Release on March 28, 2023
07 mars 2023 03h38 HE
|
Burning Rock Biotech Limited
GUANGZHOU, China, March 07, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation...
Burning Rock provides an update on 2022 revenue guidance
17 janv. 2023 20h37 HE
|
Burning Rock Biotech Limited
GUANGZHOU, China, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation...
Burning Rock Received FDA Breakthrough Device Designation for its OverC™ Multi-Cancer Detection Blood Test
03 janv. 2023 09h25 HE
|
Burning Rock Biotech Limited
IRVINE, Calif., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Burning Rock (NASDAQ/LSE: BNR), a company focused on the application of next generation sequencing (NGS) technology in the field of precision...
Burning Rock Reports Third Quarter 2022 Financial Results
15 nov. 2022 21h20 HE
|
Burning Rock Biotech Limited
GUANGZHOU, China, Nov. 15, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation...
Admission to Trading on the London Stock Exchange
01 nov. 2022 06h10 HE
|
Burning Rock Biotech Limited
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN OR ANY OTHER JURISDICTION WHERE SUCH DISTRIBUTION...
Burning Rock Announces Publication of Prospectus in connection with Direct Listing on the London Stock Exchange
27 oct. 2022 07h50 HE
|
Burning Rock Biotech Limited
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN OR ANY OTHER JURISDICTION WHERE SUCH DISTRIBUTION...